Announcements and Notices - [Other - Business Update]

Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.

Voluntary Announcement - The Interim Analysis Of A Pivotal Phase Ii/Iii Clinical Trial
Of Kn026 Has Met The Primary Endpoint Of Pfs

Voluntary Announcement - Research Updates Of Jskn021 And Jskn022 For Presentation
At 2025 Aacr Annual Meeting

Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]

2024 Environmental, Social And Governance Report

Financial Statements/ESG Information - [Annual Report]

2024 Annual Report

Announcements and Notices - [Share Scheme]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Alphamab Co Ltd (9966 HK)

Voluntary Announcement - The Interim Analysis Of A Pivotal Phase Ii/Iii Clinical Trial Of Kn026 Has Met The Primary Endpoint Of Pfs

Voluntary Announcement - Research Updates Of Jskn021 And Jskn022 For Presentation At 2025 Aacr Annual Meeting

2024 Environmental, Social And Governance Report

2024 Annual Report

(1) Grant Of Share Options Under The Post-Ipo Share Option Scheme; And (2) Grant Of Award Shares Under The Restricted Share Award Scheme

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)